{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:28:45Z","timestamp":1793698125442,"version":"4.5.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","jenonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Emergency Nursing"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jen.2026.07.012","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T21:04:46Z","timestamp":1786741486000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond Necrosis: Early Recognition of Xylazine-Associated Wounds in Emergency Nursing Practice"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8673-5693","authenticated-orcid":false,"given":"Alexis","family":"Skuras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jen.2026.07.012_bib1","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/jamapsychiatry.2022.2756","article-title":"Estimating the prevalence of substance use disorders in the US using the benchmark multiplier method","volume":"79","author":"Mojtabai","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"16","key":"10.1016\/j.jen.2026.07.012_bib2","first-page":"1401","article-title":"Emergency clinician buprenorphine initiation, subsequent prescriptions, and continuous prescriptions","volume":"333","author":"Dekker","year":"2025","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jen.2026.07.012_bib3","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.annemergmed.2021.04.023","article-title":"Consensus recommendations on the treatment of opioid use disorder in the emergency department","volume":"78","author":"Hawk","year":"2021","journal-title":"Ann Emerg Med"},{"issue":"2","key":"10.1016\/j.jen.2026.07.012_bib4","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDra2200292","article-title":"Medical complications of injection drug use - part I","volume":"2","author":"Rich","year":"2023","journal-title":"NEJM Evid"},{"issue":"6","key":"10.1016\/j.jen.2026.07.012_bib5","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/jamainternmed.2023.7282","article-title":"Caring for hospitalized adults with opioid use disorder in the era of fentanyl: a review","volume":"184","author":"Englander","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"4","key":"10.1016\/j.jen.2026.07.012_bib6","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/ADM.0000000000001132","article-title":"Widespread distribution of xylazine detected throughout the United States in healthcare patient samples","volume":"17","author":"Holt","year":"2023","journal-title":"J Addict Med"},{"key":"10.1016\/j.jen.2026.07.012_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104154","article-title":"Xylazine in the drug supply: emerging threats and lessons learned in areas with high levels of adulteration","volume":"120","author":"Quijano","year":"2023","journal-title":"Int J Drug Policy"},{"issue":"23","key":"10.1016\/j.jen.2026.07.012_bib8","doi-asserted-by":"crossref","first-page":"e1219","DOI":"10.5435\/JAAOS-D-24-00125","article-title":"Management of xylazine-induced soft-tissue necrosis: a review of 20 cases","volume":"32","author":"Retrouvey","year":"2024","journal-title":"J Am Acad Orthop Surg"},{"issue":"suppl 5","key":"10.1016\/j.jen.2026.07.012_bib9","doi-asserted-by":"crossref","first-page":"S359","DOI":"10.1097\/SAP.0000000000004616","article-title":"Surgical management of xylazine-associated wounds: a retrospective review and algorithmic approach","volume":"96","author":"Makhoul","year":"2026","journal-title":"Ann Plast Surg"},{"issue":"7","key":"10.1016\/j.jen.2026.07.012_bib10","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1111\/add.70362","article-title":"Theorizing causality: a qualitative study of xylazine-related wound diversity and perceived etiology among people who inject drugs","volume":"121","author":"German","year":"2026","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.jen.2026.07.012_bib11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/jamadermatol.2024.4253","article-title":"Wound characteristics among patients exposed to xylazine","volume":"161","author":"Lutz","year":"2025","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.jen.2026.07.012_bib12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jhsg.2024.05.003","article-title":"Xylazine-associated wounds of the upper extremity: evaluation and algorithmic surgical strategy","volume":"6","author":"Tosti","year":"2024","journal-title":"J Hand Surg Glob Online"},{"issue":"6","key":"10.1016\/j.jen.2026.07.012_bib13","doi-asserted-by":"crossref","first-page":"ofaf299","DOI":"10.1093\/ofid\/ofaf299","article-title":"Multidisciplinary guidance to care for persons with xylazine-associated wounds","volume":"12","author":"Yang","year":"2025","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"10.1016\/j.jen.2026.07.012_bib15","doi-asserted-by":"crossref","first-page":"E185","DOI":"10.1097\/ASW.0000000000000436","article-title":"Xylazine-associated wounds: a scoping review of clinical presentation and management","volume":"39","author":"Vaile","year":"2026","journal-title":"Adv Skin Wound Care"},{"key":"10.1016\/j.jen.2026.07.012_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2025.104716","article-title":"\u201cWe can\u2019t change that while they\u2019re in the hospital\u201d: unveiling the manifestations of infrastructural violence and wound care for people who inject drugs","volume":"137","author":"Block","year":"2025","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.jen.2026.07.012_bib17","article-title":"Stigma from healthcare professionals and care-limiting behaviors in individuals with substance use disorders: a mixed-methods study","volume":"63","author":"Luderer","year":"2026","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.jen.2026.07.012_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2024.112390","article-title":"Drug use practices and wound care experiences in the age of xylazine adulteration","volume":"263","author":"Jawa","year":"2024","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jen.2026.07.012_bib19","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.drugalcdep.2018.06.010","article-title":"Negative experiences of pain and withdrawal create barriers to abscess care for people who inject heroin: a mixed methods analysis","volume":"190","author":"Summers","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.jen.2026.07.012_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/ADM.0000000000001245","article-title":"Xylazine-associated wounds: clinical experience from a low-barrier wound care clinic in Philadelphia","volume":"18","author":"McFadden","year":"2024","journal-title":"J Addict Med"}],"container-title":["Journal of Emergency Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0099176726002503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0099176726002503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:05:09Z","timestamp":1793696709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0099176726002503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":19,"alternative-id":["S0099176726002503"],"URL":"https:\/\/doi.org\/10.1016\/j.jen.2026.07.012","relation":{},"ISSN":["0099-1767"],"issn-type":[{"value":"0099-1767","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond Necrosis: Early Recognition of Xylazine-Associated Wounds in Emergency Nursing Practice","name":"articletitle","label":"Article Title"},{"value":"Journal of Emergency Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jen.2026.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Emergency Nurses Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}